Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 13 of 50:
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 2C DOXAZOSIN Serotonin 5-HT2C 93% .544uM .285uM View
5-hydroxytryptamine (serotonin) receptor 2C DROPERIDOL Serotonin 5-HT2C 93% .454uM .238uM View
adrenergic receptor, alpha 1d (Non-specific probe) DROPERIDOL Adrenergic alpha1D 93% .083uM .041uM View
cholinergic receptor, muscarinic 3 DIPHENHYDRAMINE Muscarinic M3 93% .647uM .137uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DISULFIRAM Dopamine Transporter 93% 4.637uM 3.684uM View
adrenergic receptor, alpha 1d (Non-specific probe) PIPAMAZINE Adrenergic alpha1D 93% .001944uM .000955uM View
calcium channel, voltage-dependent, beta 3 subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, beta 2 subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, alpha 1F subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, beta 1 subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
ATPase, Na+/K+ transporting, alpha 1 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) HEXACHLOROPHENE Protein Tyrosine Kinase, HER2 Receptor 92% 3.3188uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) HEXACHLOROPHENE Protein Tyrosine Kinase, HER2 Receptor 92% 3.3188uM NoneNone View
mitogen activated protein kinase 1 HEXACHLOROPHENE Protein Serine/Threonine Kinase, ERK2 92% .196uM NoneNone View
mitogen-activated protein kinase 1 HEXACHLOROPHENE Protein Serine/Threonine Kinase, ERK2 92% .196uM NoneNone View
Cytochrom P450-2D6 monooxygenase DIMENHYDRINATE CYP450-2D6 Inhibition 92% 1.509uM NoneNone View
adenosine A2a receptor HEXACHLOROPHENE Adenosine A2A 92% 1.6138uM .906uM View
A3 adenosine receptor HEXACHLOROPHENE Adenosine A3 92% .6389uM .3611uM View
5-hydroxytryptamine (serotonin) receptor 2C FLUNARIZINE Serotonin 5-HT2C 92% .669uM .351uM View
5-hydroxytryptamine (serotonin) receptor 2A METHAPYRILENE Serotonin 5-HT2A 92% .628uM .18uM View
cholinergic receptor, muscarinic 5 CINNARIZINE Muscarinic M5 92% .759uM .545uM View
cholinergic receptor, muscarinic 4 DIMENHYDRINATE Muscarinic M4 92% .57uM .08uM View
cholinergic receptor, muscarinic 1 CYCLIZINE Muscarinic M1 92% .675uM .163uM View
calcium channel, voltage-dependent, gamma subunit 8 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 7 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 6 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 5 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 4 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 3 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 2 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 1 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, beta 4 subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, beta 3 subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, beta 2 subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, alpha 1F subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, beta 1 subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CINNARIZINE Calcium Channel Type L, Dihydropyridine 92% .846uM .544uM View
calcium channel, voltage-dependent, gamma subunit 8 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 7 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 6 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 5 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 4 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 3 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 2 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, gamma subunit 1 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, beta 4 subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, beta 3 subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, beta 2 subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, alpha 1F subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, beta 1 subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TERFENADINE Calcium Channel Type L, Dihydropyridine 92% .779uM .501uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 LACIDIPINE CYP450-3A4 Inhibition 92% .9uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 L-744832 CYP450-3A4 Inhibition 92% 3uM NoneNone View
cholinergic receptor, muscarinic 1 BERBERINE CHLORIDE Muscarinic M1 92% 3.08uM .742uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 BITHIONOL Adrenergic, Norepinephrine Transporter 92% 1.235uM 1.225uM View
dopamine receptor D1A ALPHA-ERGOCRYPTINE Dopamine D1 92% .403uM .202uM View
epidermal growth factor receptor DOBUTAMINE Protein Tyrosine Kinase, EGF Receptor 92% 5.551uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CLOSANTEL Protein Tyrosine Kinase, HER2 Receptor 92% 2.468uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CLOSANTEL Protein Tyrosine Kinase, HER2 Receptor 92% 2.468uM NoneNone View
5-hydroxytryptamine receptor 6 MAPROTILINE Serotonin 5-HT6 92% .892uM .414uM View
cholinergic receptor, muscarinic 4 MAPROTILINE Muscarinic M4 92% .413uM .058uM View
dopamine receptor 2 BUSPIRONE Dopamine D2L 92% .323uM .108uM View
glycine receptor, alpha 3 IVERMECTIN Glycine, Strychnine-Sensitive 92% .3747uM .2118uM View
5-hydroxytryptamine (serotonin) receptor 2A DAPIPRAZOLE Serotonin 5-HT2A 91% .606uM .173uM View
opioid receptor, kappa 1 RALOXIFENE Opiate kappa 91% 1.602uM .641uM View
mitogen activated protein kinase 1 TRIBROMSALAN Protein Serine/Threonine Kinase, ERK2 91% .623uM NoneNone View
mitogen-activated protein kinase 1 TRIBROMSALAN Protein Serine/Threonine Kinase, ERK2 91% .623uM NoneNone View
dopamine receptor D1A ASTEMIZOLE Dopamine D1 91% 4.01uM 2.005uM View
cholinergic receptor, muscarinic 4 CLOMIPHENE Muscarinic M4 91% 1.651uM .23uM View
opioid receptor, kappa 1 HALOPROGIN Opiate kappa 91% 1.147uM .459uM View
dopamine receptor D1A DISULFIRAM Dopamine D1 91% 2.158uM 1.079uM View
sodium channel, voltage-gated, type III, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type II, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type II, alpha 2 VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type I, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type I, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
5-hydroxytryptamine (serotonin) receptor 2C MEPAZINE Serotonin 5-HT2C 91% .495uM .259uM View
5-hydroxytryptamine (serotonin) receptor 2C 2-ACETYLAMINOFLUORENE Serotonin 5-HT2C 91% 2.143uM 1.122uM View
5-hydroxytryptamine (serotonin) receptor 2B 2-ACETYLAMINOFLUORENE Serotonin 5-HT2B 91% 3.17uM 2.017uM View
Cytochrom P450-2C19 monooxygenase 4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE CYP450-2C19 Inhibition 91% .4uM NoneNone View
Cytochrom P450-1A2 monooxygenase PRIMAQUINE CYP450-1A2 Inhibition 91% .1824uM NoneNone View
adrenergic receptor, alpha 2a QUINACRINE Imidazoline I2, Central 91% 1.521uM 1.014uM View
adrenergic receptor, alpha 2c (Non-specific probe) QUINACRINE Imidazoline I2, Central 91% 1.521uM 1.014uM View
5-hydroxytryptamine (serotonin) receptor 2C SERTRALINE Serotonin 5-HT2C 91% 1.083uM .5673uM View
dopamine receptor D1A NORTRIPTYLINE Dopamine D1 91% .539uM .269uM View
calcium channel, voltage-dependent, gamma subunit 8 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 7 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 6 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 5 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 4 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 3 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 2 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, gamma subunit 1 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, beta 4 subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, beta 3 subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, beta 2 subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, alpha 1F subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, beta 1 subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NORTRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% 1.887uM 1.835uM View
adrenergic receptor, alpha 2a OLANZAPINE Adrenergic alpha2A 91% .541uM .203uM View
5-hydroxytryptamine (serotonin) receptor 2A OXICONAZOLE Serotonin 5-HT2A 91% 4.163uM 1.1894uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 8 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 7 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 6 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 5 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 4 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 3 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 2 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, gamma subunit 1 ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, beta 4 subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, beta 3 subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, beta 2 subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, alpha 1F subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, beta 1 subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit ORPHENADRINE Calcium Channel Type L, Phenylalkylamine 91% 1.746uM 1.698uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 ORPHENADRINE Serotonin Transporter 91% .458uM .243uM View
adrenergic receptor, beta 2 SALBUTAMOL Adrenergic beta2 91% .8102uM .557uM View
acetylcholinesterase (YT blood group) CETYLPYRIDINIUM BROMIDE Acetylcholinesterase 91% 2.753uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase CETYLPYRIDINIUM BROMIDE Acetylcholinesterase 91% 2.753uM NoneNone View
acetylcholinesterase CETYLPYRIDINIUM BROMIDE Acetylcholinesterase 91% 2.753uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) PROMETHAZINE Adrenergic alpha1D 91% .183uM .09uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CANDESARTAN Protein Tyrosine Kinase, HER2 Receptor 91% 5.9472uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CANDESARTAN Protein Tyrosine Kinase, HER2 Receptor 91% 5.9472uM NoneNone View
calcium channel, voltage-dependent, beta 3 subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, beta 2 subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
sodium channel, nonvoltage-gated 1 alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type X, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IX, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage gated, type VIII, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type VII, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IV, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IV, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
progesterone receptor MEDROXYPROGESTERONE Progesterone 91% .711uM .093uM View
angiotensin 1 converting enzyme 1 ENALAPRIL Protease, Angiotensin Converting Enzyme 91% 3.33uM NoneNone View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ENALAPRIL Protease, Angiotensin Converting Enzyme 91% 3.33uM NoneNone View
arachidonate 15-lipoxygenase ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
arachidonate 15-lipoxygenase, second type ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
arachidonate 15-lipoxygenase ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B ETHINYLESTRADIOL Serotonin 5-HT4 91% 7.953uM 1.326uM View
5-hydroxytryptamine (serotonin) receptor 4 ETHINYLESTRADIOL Serotonin 5-HT4 91% 7.953uM 1.326uM View
5-hydroxytryptamine (serotonin) receptor 2C TIRILAZAD Serotonin 5-HT2C 91% .718uM .376uM View
adrenergic receptor, alpha 2a AMLODIPINE Adrenergic alpha2A 91% .602uM .226uM View
calcium channel, voltage-dependent, gamma subunit 5 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 4 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 3 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 2 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 1 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 4 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 3 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 2 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, alpha 1F subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 1 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 8 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 7 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 6 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
Protein-tyrosine kinase, Fyn U-78517F Protein Tyrosine Kinase, Fyn 91% 1.649uM NoneNone View
Sigma-2 Receptor AMIODARONE Sigma2 91% .117uM .072uM View
calcium channel, voltage-dependent, gamma subunit 8 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View